Roche NimbleGen announces NewGene as first certified service provider in the UK

Roche NimbleGen (SWX:RO)(SWX:ROG)(Pink Sheets:RHHBY) announces that Newcastle-based genomic services provider NewGene Ltd. has officially become a Certified Service Provider (CSP) for NimbleGen Sequence Capture. They will provide services for NimbleGen Sequence Capture Arrays with sequencing on the Genome Sequencer FLX System from 454 Life Sciences, a Roche Company. NewGene Ltd. has passed a comprehensive certification test plan to officially become a member of the Roche NimbleGen Certified Service Provider network. They will process customer gDNA samples for genomic enrichment, using the complete NimbleGen Sequence Capture Array workflow optimized for 454 GS FLX Titanium Series sequencing.

“Roche NimbleGen welcomes NewGene Ltd. as our first certified service provider in the United Kingdom. NewGene's highly skilled professionals and use of the latest next generation sequencing technologies, including our Sequence Capture arrays, will make this powerful technique widely available to researchers throughout the UK”

"NewGene is very excited to be entering into this collaboration with Roche NimbleGen as its UK-based certified service provider. The ability to couple NimbleGen Sequence Capture technology with our next generation sequencing capabilities will provide significant scientific, technical and economic benefits to our UK customers" said David Huntley, CEO at NewGene Ltd.

"Roche NimbleGen welcomes NewGene Ltd. as our first certified service provider in the United Kingdom. NewGene's highly skilled professionals and use of the latest next generation sequencing technologies, including our Sequence Capture arrays, will make this powerful technique widely available to researchers throughout the UK " said Dr. Frank Pitzer, CEO of Roche NimbleGen, Inc.

SOURCE NewGene

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists decode ovarian aging with groundbreaking molecular atlas